Allianz Asset Management
HAE icon

Allianz Asset Management’s Haemonetics HAE Stock Holding History

Allianz Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,240
Closed -$316K – 2031
2025
Q2 		$316K Sell
4,240
-563
-12% -$37.3K ﹤0.01% 1901
2025
Q1 		$305K Sell
4,803
-32,795
-87% -$2.23M ﹤0.01% 2036
2024
Q4 		$2.94M Sell
37,598
-27,962
-43% -$2.25M ﹤0.01% 1270
2024
Q3 		$5.27M Sell
65,560
-345
-0.5% -$27.9K 0.01% 1018
2024
Q2 		$5.45M Sell
65,905
-279
-0.4% -$24.5K 0.01% 923
2024
Q1 		$5.65M Buy
66,184
+5,007
+8% +$393K 0.01% 832
2023
Q4 		$5.23M Buy
61,177
+829
+1% +$71.7K 0.01% 898
2023
Q3 		$5.41M Buy
60,348
+8,192
+16% +$731K 0.01% 958
2023
Q2 		$4.44M Sell
52,156
-81,268
-61% -$6.87M 0.01% 920
2023
Q1 		$11M Buy
133,424
+8,509
+7% +$689K 0.02% 661
2022
Q4 		$9.82M Buy
124,915
+81,137
+185% +$6.52M 0.02% 687
2022
Q3 		$3.24M Buy
+43,778
New +$3.14M 0.01% 1065
2021
Q4 		– Sell
-75,654
Closed -$5.34M – 2602
2021
Q3 		$5.34M Buy
75,654
+1,270
+2% +$80.1K ﹤0.01% 1254
2021
Q2 		$4.96M Hold
74,384
– – ﹤0.01% 1118
2021
Q1 		$8.26M Sell
74,384
-80,394
-52% -$9.95M 0.01% 890
2020
Q4 		$18.4M Sell
154,778
-8,910
-5% -$959K 0.02% 651
2020
Q3 		$14.3M Sell
163,688
-35,082
-18% -$3.07M 0.02% 669
2020
Q2 		$17.8M Buy
198,770
+13,847
+7% +$1.4M 0.02% 675
2020
Q1 		$18.4M Sell
184,923
-6,863
-4% -$744K 0.02% 597
2019
Q4 		$22M Buy
191,786
+22,355
+13% +$2.7M 0.02% 745
2019
Q3 		$21.4M Buy
169,431
+16,381
+11% +$2.08M 0.02% 747
2019
Q2 		$18.4M Buy
153,050
+20,251
+15% +$1.99M 0.02% 848
2019
Q1 		$11.6M Buy
132,799
+7,329
+6% +$667K 0.01% 1072
2018
Q4 		$12.6M Sell
125,470
-5,518
-4% -$580K 0.01% 995
2018
Q3 		$15M Sell
130,988
-2,284
-2% -$236K 0.01% 1060
2018
Q2 		$12M Buy
133,272
+19,642
+17% +$1.66M 0.01% 1174
2018
Q1 		$8.31M Buy
+113,630
New +$7.8M 0.01% 1332

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allianz Asset Management's HAE Position: Q3 2025 in Review

Allianz Asset Management sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 4,240 shares — an estimated $316K sold.

Allianz Asset Management first reported a position in HAE in Q1 2018 and held it in 27 quarters. The position peaked at $22M in Q4 2019. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Allianz Asset Management reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Allianz Asset Management sold 4,240 Haemonetics shares in Q3 2025, an estimated $316K.
  • Allianz Asset Management first reported a position in Haemonetics in Q1 2018 and held it in 27 quarters.
  • Allianz Asset Management's Haemonetics position peaked at $22M in Q4 2019.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Allianz Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.